封面
市場調查報告書
商品編碼
1477249

血糖監測市場,依類型、依組件、依最終用戶、依地理位置

Blood Glucose Monitoring Market, By Type, By Component, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計2024年全球血糖監測市場價值為188.5億美元,預計到2031年將達到371.4億美元,2024年至2031年年複合成長率(CAGR)為10.2%。

報告範圍 報告詳情
基準年: 2023年 2024 年市場規模: 188.5 億美元
歷史數據: 2019年至2023年 預測期: 2024年至2031年
預測 2024 年至 2031 年複合年成長率: 10.20% 2031 年價值預測: 371.4 億美元
圖 1. 2024 年血糖監測市場佔有率 (%)(依地區)
血糖監測市場 - IMG1

血糖監測對於管理糖尿病至關重要,因為它可以幫助患者監測血糖水平並定期採取糾正措施。自我監測設備的便利性和可負擔性,以及人們對糖尿病照護意識的不斷提高,推動了血糖監測解決方案在全球範圍內得到更廣泛的採用。此外,技術進步促使創新監控設備的開發,這些設備具有增強的準確性、便利性和連接性,預計將在未來幾年進一步推動市場成長。

市場動態:

由於全球糖尿病人口不斷增加以及人們對糖尿病管理的日益關注,全球血糖監測市場一直在穩步成長。肥胖和久坐生活方式日益普遍等多種因素正在加劇全球糖尿病負擔,這反過來又推動了血糖監測設備的採用。此外,方便用戶使用且負擔得起的監測解決方案的開發以及已開發地區有利的報銷政策正在鼓勵更多地採用自我監測設備。然而,與先進血糖監測儀相關的高成本仍然是一個主要課題,特別是在發展中國家。此外,網路威脅和資料外洩的漏洞可能會阻礙向連網監控設備的過渡。儘管如此,持續的技術升級,包括微創連續血糖監測系統的開發,為市場參與者帶來了光明的前景。

研究的主要特點:

  • 該報告對全球血糖監測市場進行了深入分析,並提供了以2023年為基準年的預測期(2024-2031)的市場規模(十億美元)和年複合成長率(CAGR%)。
  • 它闡明了不同區隔市場的潛在收入成長機會,並解釋了該市場有吸引力的投資主張矩陣。
  • 這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
  • 它根據以下參數描述了全球血糖監測市場的主要參與者——公司亮點、產品組合、主要亮點、財務表現和策略。
  • 該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球血糖監測市場迎合了該行業的各個利益相關者,包括投資者、供應商、產品製造商、分銷商、新進業者和金融分析師。
  • 利害關係人可以透過用於分析全球血糖監測市場的各種策略矩陣輕鬆做出決策。

目錄

第1章:研究目標與假設

  • 研究目標
  • 假設
  • 縮寫

第 2 章:市場範圍

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map (COM)

第 3 章:市場動態、法規與趨勢分析

  • 市場動態
    • 促進要素
    • 限制
    • 機會
  • 影響分析
  • 市場走向
  • 最近的發展
  • 監管場景
  • 技術進步
  • 製造商收入
  • 收購和合作場景
  • 產品發布/批准
  • 資金和投資
  • PEST分析
  • 波特的分析

第 4 章:全球血糖監測市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • 整體影響
  • 政府舉措
  • COVID-19 對市場的影響

第 5 章:2019 - 2031 年全球血糖監測市場(依類型)(十億美元)

  • 概述
  • 自我監測血糖設備
  • 連續血糖監測裝置
  • 快速血糖監測設備

第 6 章:2019 - 2031 年全球血糖監測市場(依組成部分)(十億美元)

  • 概述
  • 血糖儀設備
  • 試紙條
  • 柳葉刀
  • 感應器
  • 其他

第 7 章:全球血糖監測市場,依最終用戶分類,2019 - 2031 年(十億美元)

  • 概述
  • 醫院
  • 家庭護理設置
  • 門診護理設置
  • 其他

第 8 章:2019 - 2031 年全球血糖監測市場(依地區)(十億美元)

  • 介紹
  • 北美洲
  • 美國
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 歐洲其他地區
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 東協
  • 澳洲
  • 韓國
  • 亞太地區其他地區
  • 中東
  • 海灣合作理事會
  • 以色列
  • 中東其他地區
  • 非洲
  • 北非
  • 中非
  • 南非

第 9 章:競爭格局

  • 公司簡介
    • Medtronic
    • ACON Laboratories, Inc.
    • Senseonics, Inc.
    • Medisana AG
    • Bionime Corporation
    • AgaMatrix Inc.
    • ARKRAY, Inc.
    • Rossmax International Ltd.
    • Dexcom, Inc.
    • Nipro Group
    • B. Braun SE
    • Nova Biomedical
    • LifeScan IP Holdings, LLC
    • Ascensia Diabetes Care Holdings AG
    • Nemaura
    • Terumo Corporation
    • F. Hoffmann-La Roche Ltd.

第 10 章:分析師觀點

  • 命運之輪
  • 分析師觀點
  • 連貫的機會圖

第 11 章:參考文獻與研究方法

  • 參考
  • 研究方法論
簡介目錄
Product Code: CMI5382

The global blood glucose monitoring market is estimated to be valued at USD 18.85 Bn in 2024 and is expected to reach USD 37.14 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.2% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 18.85 Bn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 10.20% 2031 Value Projection: US$ 37.14 Bn
Figure 1.Blood Glucose Monitoring Market Share (%), By Region, 2024
Blood Glucose Monitoring Market - IMG1

Blood glucose monitoring is crucial for managing diabetes as it helps patients monitor their blood sugar levels and take corrective measures on a regular basis. Easy availability and affordability of self-monitoring devices along with growing awareness about diabetes care have been driving the greater adoption of blood glucose monitoring solutions globally. In addition, technological advancements leading to the development of innovative monitoring devices with enhanced features for accuracy, convenience, and connectivity are expected to further propel the market growth in the coming years.

Market Dynamics:

The global blood glucose monitoring market has been witnessing steady growth attributed to rising diabetic population worldwide coupled with growing focus on diabetes management. Various factors, such as increasing prevalence of obesity and sedentary lifestyles, are contributing to the diabetes burden globally, which, in turn, is driving the adoption of blood glucose monitoring devices. Additionally, the development of user-friendly and affordable monitoring solutions along with favorable reimbursement policies in developed regions are encouraging the greater uptake of self-monitoring devices. However, high costs associated with advanced blood glucose monitors remains a key challenge, especially in developing countries. Moreover, vulnerabilities to cyber threats and data breaches could hamper the transition towards connected monitoring devices. Nonetheless, ongoing technological upgrades including the development of minimally invasive continuous glucose monitoring systems presents bright prospects for market players.

Key Features of the Study:

  • This report provides an in-depth analysis of the global blood glucose monitoring market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global blood glucose monitoring market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study Medtronic, ACON Laboratories, Inc., Senseonics, Inc., Medisana AG, Bionime Corporation, AgaMatrix Inc., ARKRAY, Inc., Rossmax International Ltd., Dexcom, Inc., Nipro Group, B. Braun SE, Nova Biomedical, LifeScan IP Holdings, LLC, Ascensia Diabetes Care Holdings AG, Nemaura, Terumo Corporation, and Hoffmann-La Roche Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global blood glucose monitoring market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood glucose monitoring market.

Detailed Segmentation-

  • By Type:
    • Self-monitoring blood glucose devices
    • Continuous glucose monitoring devices
    • Flash glucose monitoring devices
  • By Component:
    • Glucometer devices
    • Test strips
    • Lancets
    • Sensors
    • Others
  • By End User:
    • Hospitals
    • Homecare Settings
    • Ambulatory Care Settings
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Medtronic
    • ACON Laboratories, Inc.
    • Senseonics, Inc.
    • Medisana AG
    • Bionime Corporation
    • AgaMatrix Inc.
    • ARKRAY, Inc.
    • Rossmax International Ltd.
    • Dexcom, Inc.
    • Nipro Group
    • Braun SE
    • Nova Biomedical
    • LifeScan IP Holdings, LLC
    • Ascensia Diabetes Care Holdings AG
    • Nemaura
    • Terumo Corporation
    • Hoffmann-La Roche Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Component
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Regulatory Scenario
  • Technological Advancements
  • Manufacturer Revenue
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Blood Glucose Monitoring Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Blood Glucose Monitoring Market, By Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Self-monitoring blood glucose devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Continuous glucose monitoring devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Flash glucose monitoring devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Blood Glucose Monitoring Market, By Component, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Glucometer devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Test strips
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Lancets
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Sensors
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Blood Glucose Monitoring Market, By End User, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Homecare Settings
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Ambulatory Care Settings
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Blood Glucose Monitoring Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Regions, 2020-2031
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Company Profiles
    • Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • ACON Laboratories, Inc.
    • Senseonics, Inc.
    • Medisana AG
    • Bionime Corporation
    • AgaMatrix Inc.
    • ARKRAY, Inc.
    • Rossmax International Ltd.
    • Dexcom, Inc.
    • Nipro Group
    • B. Braun SE
    • Nova Biomedical
    • LifeScan IP Holdings, LLC
    • Ascensia Diabetes Care Holdings AG
    • Nemaura
    • Terumo Corporation
    • F. Hoffmann-La Roche Ltd.

10. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact